Avaleht/Aktsiad/BMRA

BMRA

USD

Biomerica Inc. Common Stock

$3.320-0.180 (-5.143%)

Reaalajas hind

Healthcare

Meditsiiniseadmed

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$3.500

Kõrge

$3.520

Madal

$3.275

Maht

0.06M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

8.7M

Tööstusharu

Meditsiiniseadmed

Riik

United States

Kauplemisstatistika

Keskmine maht

0.03M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.92Praegune $3.320Kõrge $10.16

Seotud uudised

6. juuni 2025 · 13:30

GlobeNewswire

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Mr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent

Vaata rohkem

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

5. juuni 2025 · 12:19

GlobeNewswire

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data

Vaata rohkem

Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

22. mai 2025 · 12:19

GlobeNewswire

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind

Vaata rohkem